0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight essential thrombocythemia global api manufacturers marketed phase iii drugs 0.Your search for "" gave back 1533063 results.
E3 Ubiquitin Protein Ligase XIAP - Pipeline Review, H2 2019 Summary E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or...
Catalog:
Global Markets Direct
November 2019
Price: USD 3,500.00
Bronchopulmonary Dysplasia (Respiratory) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
July 2021
Price: USD 2,000.00
Asia Pacific pharmaceutical CDMO market will grow by 8.3% annually with a total addressable market cap of $725.2 billion over 2020-2030 owing to the...
Catalog:
Grace Market Data
December 2020
Price: USD 3,300.00
Europe pharmaceutical CDMO market accounted for $37.17 billion in 2019 and will grow by 6.7% annually over 2020-2030 owing to the rising demand for...
Catalog:
Grace Market Data
December 2020
Price: USD 3,300.00
Hepatitis A Virus Cellular Receptor 2 - Pipeline Review, H2 2019 Summary Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Global pharmaceutical CDMO market will reach $289.2 billion by 2030, growing by 6.9% annually over 2020-2030 driven by increasing demand for...
Catalog:
Grace Market Data
December 2020
Price: USD 3,900.00
Congestive Heart Failure (Heart Failure) (Cardiovascular) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
June 2021
Price: USD 2,500.00
Osteosarcoma (Oncology) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
July 2021
Price: USD 2,000.00
In recent years, multinational pharmaceutical companies have focused on core business by selling API and preparation factories. We estmiate that with...
Catalog:
AEI
May 2021
Price: USD 3,000.00
E3 Ubiquitin Protein Ligase XIAP - Pipeline Review, H1 2019 Summary According to the recently published report 'E3 Ubiquitin Protein Ligase XIAP...
Catalog:
Global Markets Direct
June 2019
Price: USD 3,500.00
India is expected to witness a remarkable rise in healthcare infrastructure in upcoming years. There will there be a dramatic rise in the type and...
Catalog:
NAVADHI
June 2019
Price: USD 1,000.00
Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest...
Catalog:
Global Markets Direct
April 2022
Price: USD 2,500.00
Melanocyte Stimulating Hormone Receptor - Drugs In Development, 2021 Summary Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
Colitis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis -...
Catalog:
Global Markets Direct
January 2018
Price: USD 2,000.00
